SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-19-016982
Filing Date
2019-03-29
Accepted
2019-03-29 16:10:18
Documents
67
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv516113_10k.htm 10-K 908626
2 EXHIBIT 10.49 tv516113_ex10-49.htm EX-10.49 142864
3 EXHIBIT 23.1 tv516113_ex23-1.htm EX-23.1 2635
4 EXHIBIT 31.1 tv516113_ex31-1.htm EX-31.1 7624
5 EXHIBIT 32.1 tv516113_ex32-1.htm EX-32.1 4592
  Complete submission text file 0001144204-19-016982.txt   7321421

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgrx-20181231.xml EX-101.INS 2069833
7 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20181231.xsd EX-101.SCH 47563
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20181231_cal.xml EX-101.CAL 42981
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20181231_def.xml EX-101.DEF 291110
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20181231_lab.xml EX-101.LAB 344196
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20181231_pre.xml EX-101.PRE 349691
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15070 | Film No.: 19716520
SIC: 2834 Pharmaceutical Preparations